Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
PreveCeutical Medical Inc. (PRVCF) had Return on Tangible Equity of 5.25% for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-0.25M |
|
-- |
|
-- |
|
$0.18M |
|
$-0.18M |
|
$-0.07M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.18M |
|
$-0.18M |
|
536.94M |
|
536.94M |
|
$-0.00 |
|
$-0.00 |
|
| Balance Sheet Financials | |
$0.25M |
|
$0.00M |
|
$0.08M |
|
$0.33M |
|
$4.89M |
|
$0.05M |
|
$0.05M |
|
$4.94M |
|
$-4.61M |
|
$-4.69M |
|
$-4.61M |
|
541.70M |
|
| Cash Flow Statement Financials | |
$-0.26M |
|
$-0.00M |
|
$0.27M |
|
$0.00M |
|
$0.00M |
|
$-0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-0.01 |
|
-0.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
5.34% |
|
|
Return on Tangible Equity |
5.25% |
-73.84% |
|
5.40% |
|
$-0.01 |
|
$-0.00 |
|
$-0.00 |
|